Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Retirement Planning and Advisory Services Under PFRDA Regulations 2016
00:10:00
Mining Project in Tanzania Nears Funding Completion
00:10:00
Driving Innovation and Equity: Jeremiah Gordon on Growth Funds and Impact Investing | General Counsel, CapitalG
00:10:00
Investing in and building groundbreaking companies at their best|Ammar Amdani,Managing Partner,Adapt Ventures
00:10:00
specializing in the craft of building great companies|Brian Murray,Partner COO,Craft Ventures
00:10:00
Navigating European High Yield Bonds: Madelaine Jones' Insights on Bloomberg Markets (2022)
00:10:00
Welcome to Pope Financial Planning: A Message from the Founder | Apryl M. Pope - Owner & Founder of Pope Financial Planning
00:10:00
Power Dynamics: Interview with Aboitiz Power President & CEO | Manny Rubio , CEO, Aboitiz Power Corp.
00:10:00
Blue Owl Capital's Role in Stable Investment Solutions | Marc Lipschultz, Co-president , Blue Owl Capital.
00:10:00
Prefer to invest alongside a lead VC check (and if there's no lead yet, they'll help the founder find one).|Zach Weinberg,General Partner,Operator Partners
00:10:00
Exploring the Evolution of Satellite Technology with Planet | Dr Will Marshall, CEO, Planet Lab.
00:10:00
Insights into Venture Capital with Bill Comfort

© 2017 - Neuhu+